The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...

An algorithm is helping to reduce the number of unnecessary hospital admissions for children with sickle cell.

Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...